<SEC-DOCUMENT>0000950142-24-001469.txt : 20240530
<SEC-HEADER>0000950142-24-001469.hdr.sgml : 20240530
<ACCEPTANCE-DATETIME>20240530084401
ACCESSION NUMBER:		0000950142-24-001469
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240530
FILED AS OF DATE:		20240530
DATE AS OF CHANGE:		20240530

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gildan Activewear Inc.
		CENTRAL INDEX KEY:			0001061894
		STANDARD INDUSTRIAL CLASSIFICATION:	APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1229

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14830
		FILM NUMBER:		241000912

	BUSINESS ADDRESS:	
		STREET 1:		600 BOULEVARD DE MAISONNEUVE OUEST
		STREET 2:		33RD FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 3J2
		BUSINESS PHONE:		5147352023

	MAIL ADDRESS:	
		STREET 1:		600 BOULEVARD DE MAISONNEUVE OUEST
		STREET 2:		33RD FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 3J2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDAN ACTIVEWEAR INC
		DATE OF NAME CHANGE:	19980515
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>eh240487648_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="margin-top: 0pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Rule 13a-16 or 15d-16 of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>the Securities Exchange Act of 1934</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 8pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="text-align: center; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt"><B>For
    the month of:  May 2024</B></FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 48%"><FONT STYLE="font-size: 10pt"><B>Commission File Number: 1-14830</B></FONT></TD></TR>
  </TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 8pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 12pt"><B>GILDAN ACTIVEWEAR INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Translation of registrant&rsquo;s name into English)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>600 de Maisonneuve Boulevard West</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>33rd Floor</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Montr&eacute;al, Qu&eacute;bec</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Canada H3A 3J2</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Form 20-F <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F <FONT STYLE="font-family: Wingdings">&#254;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="4">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"><B>GILDAN ACTIVEWEAR INC.</B></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="4">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date: May 30, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Michelle Taylor</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Michelle Taylor</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Vice-President, General Counsel and Corporate Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>&nbsp;</B></P>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 9%"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 90%"><FONT STYLE="font-size: 10pt"><B>Description of Exhibit</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="eh240487648_ex9901.htm">News Release</A></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>eh240487648_ex9901.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>EXHIBIT
99.1&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="header.jpg" ALT=""><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Gildan
Activewear Announces Increase of Normal Course Issuer Bid</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Montreal,
May&nbsp;29, 2024 </B>- Gildan Activewear Inc. (GIL: TSX and NYSE) is committed to returning capital to shareholders via share buybacks
and dividends as a key element of its capital allocation program. As previously indicated, the Company planned on resuming share repurchases
following the Annual General Meeting of shareholders which occurred on May 28, 2024. Consequently, Gildan&rsquo;s newly reconstituted
Board of Directors has now approved the resumption of share repurchases and an amended normal course issuer bid (NCIB).</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;Given
our continued execution of the Gildan Sustainable Growth strategy, our expected strong free cash flow and the strength of our balance
sheet, we are eager to resume our share repurchases as we move through 2024,&rdquo; said Glenn J. Chamandy, President and CEO.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">As
such, Gildan today announced that it has received approval from the Toronto Stock Exchange (TSX) to amend its current NCIB, which commenced
on August 9, 2023, in order to increase the maximum number of common shares that may be repurchased from 8,778,638, or 5% of its issued
and outstanding common shares as at July 31, 2023 (the reference date for the NCIB), to 17,124,249 common shares, representing 10% of
the public float as at July 31, 2023. No other terms of the NCIB have been amended.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
NCIB, which began August 9, 2023, and will end no later than August 8, 2024, is conducted by means of open market transactions on both
the TSX and the New York Stock Exchange (NYSE), or alternative Canadian trading systems, if eligible, or by such other means as may be
permitted by securities regulatory authorities, including pre-arranged crosses, exempt offers, private agreements under an issuer bid
exemption order issued by securities regulatory authorities and block purchases of common shares. Under the NCIB, Gildan may purchase
up to a maximum of 92,611 common shares daily through the facilities of the TSX, which represents 25% of the average daily trading volume
on the TSX for the six months ended July 31, 2023, in addition to purchases made on other exchanges including the NYSE.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
price to be paid by Gildan for any common shares will be the market price at the time of the acquisition, plus brokerage fees, and purchases
made under an issuer bid exemption order will be at a discount to the prevailing market price in accordance with the terms of the order.
The actual number of common shares purchased under the NCIB and the timing of such purchases will be at Gildan's discretion and shall
be subject to the limitations set out in the TSX Company Manual.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Other
than to reflect the increase in the maximum number of common shares that may be repurchased under the NCIB, the automatic securities
purchase plan (ASPP) entered into with a designated broker in relation to the NCIB on August 9, 2023 also remains unchanged. The ASPP
allows for the purchase of common shares under the NCIB, subject to certain trading parameters, at times when Gildan ordinarily would
not be permitted to purchase its common shares due to applicable regulatory restrictions or self-imposed trading black-out periods. Outside
of the predetermined black-out periods, common shares may be purchased under the NCIB based on the discretion of the Company&rsquo;s
management, in compliance with TSX rules and applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">During
the period from August 9, 2023 to May&nbsp;29, 2024, Gildan purchased and cancelled a total of 8,611,018 common shares, representing
4.9% of its issued and outstanding common shares and 5.0% of the public float as at July 31, 2023, for a total cost of US$272.5 million.
All shares purchased pursuant to the NCIB have been canceled.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gildan&rsquo;s
management and the Board of Directors believe the repurchase of common shares represents an appropriate use of Gildan&rsquo;s financial
resources and that share repurchases under the NCIB will not preclude Gildan from continuing to pursue organic growth and complementary
acquisitions.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Caution
Concerning Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain
statements included in this press release constitute &ldquo;forward-looking statements&rdquo; within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and Canadian securities legislation and regulations and are subject to important risks, uncertainties,
and assumptions. This forward-looking information includes, amongst others, statements relating to potential future purchases by Gildan
of its common shares pursuant to the NCIB and ASPP. Forward-looking statements generally can be identified by the use of conditional
or forward-looking terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;project,&rdquo; &ldquo;assume,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;plan,&rdquo; &ldquo;foresee,&rdquo; &ldquo;believe,&rdquo;
or &ldquo;continue,&rdquo; or the negatives of these terms or variations of them or similar terminology. We refer you to the Company&rsquo;s
filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, as well as the risks described
under the &ldquo;Financial risk management&rdquo;, &ldquo;Critical accounting estimates and judgments,&rdquo; and &ldquo;Risks and uncertainties&rdquo;
sections of the Company&rsquo;s most recent Management&rsquo;s Discussion and Analysis for the year ended December 31, 2023 (&ldquo;FY2023
MD&amp;A&rdquo;) for a discussion of the various factors that may affect these forward-looking statements. Material factors and assumptions
that were applied in drawing a conclusion or making a forecast or projection are also set out throughout such document.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Forward-looking
information is inherently uncertain and the results or events predicted in such forward-looking information may differ materially from
actual results or events. Material factors, which could cause actual results or events to differ materially from a conclusion or projection
in such forward-looking information, include, but are not limited to changes in general economic, financial or geopolitical conditions
globally or in one or more of the markets we serve, including the pricing and inflationary environment, and our ability to implement
our growth strategies and plans, as well as those factors listed in the FY2023 MD&amp;A under the &ldquo;Risks and uncertainties&rdquo;
section and &ldquo;Caution regarding forward-looking statements&rdquo; sections. These factors may cause the Company&rsquo;s actual performance
in future periods to differ materially from any estimates or projections of future performance expressed or implied by the forward-looking
statements included in this press release.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">There
can be no assurance that the expectations represented by our forward-looking statements will prove to be correct. The purpose of the
forward-looking statements is to provide the reader with a description of management&rsquo;s expectations regarding the Company&rsquo;s
future financial performance and may not be appropriate for other purposes. Furthermore, unless otherwise stated, the forward-looking
statements contained in this press release are made as of the date of this press release, and we do not undertake any obligation to update
publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise
unless required by applicable legislation or regulation. The forward-looking statements contained in this press release are expressly
qualified by this cautionary statement.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>About
Gildan</B></FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gildan
is a leading manufacturer of everyday basic apparel. The Company&rsquo;s product offering includes activewear, underwear and socks, sold
to a broad range of customers, including wholesale distributors, screenprinters or embellishers, as well as to retailers that sell to
consumers through their physical stores and/or e-commerce platforms and to global lifestyle brand companies. The Company markets its
products in North America, Europe, Asia Pacific, and Latin America, under a diversified portfolio of Company-owned brands including Gildan&reg;,
American Apparel&reg;, Comfort Colors&reg;, GOLDTOE&reg;, and Peds&reg;.</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gildan
owns and operates vertically integrated, large-scale manufacturing facilities which are primarily located in Central America, the Caribbean,
North America, and Bangladesh. Gildan operates with a strong commitment to industry-leading labour, environmental, and governance practices
throughout its supply chain in accordance with its comprehensive ESG program embedded in the Company&rsquo;s long-term business strategy.
More information about the Company and its ESG practices and initiatives can be found at <FONT STYLE="color: #0070c0"><U>www.gildancorp.com</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%"><P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Investor
                           inquiries:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>&nbsp;&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Jessy
    Hayem, CFA&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Vice-President,
    Head of Investor Relations&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(514)
    744-8511&nbsp;&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #0070c0"><U>jhayem@gildan.com</U></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD>
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Media
                           inquiries:</B>&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Genevieve
    Gosselin&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director,
    Global Communications and Corporate Marketing&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(514)
    343-8814&nbsp;</FONT></P>
    <P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; color: #0070c0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><U>communications@gildan.com</U>&nbsp;</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-
                                            2 -</FONT></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>header.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 header.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0,&17AI9@  34T *@    @ ! $[  (
M   4   !2H=I  0    !   !7IR=  $    H   "UNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M2&EN<W!E=&5R+"!-:6-H96QL90  !9 #  (    4   "K) $  (    4   "
MP)*1  (    #,C,  )*2  (    #,C,  .H<  <   $,   !H      <Z@
M  $
M
M
M
M
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MT]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M;_PLWP=_T'K7\S_A1_PLWP=_T'K7\S_A7RE11_9E+NP_M"IV1]6_\+-\'?\
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M?S/^%'_"S?!W_0>M?S/^%?*5%']F4N[#^T*G9'U;_P +-\'?]!ZU_,_X4?\
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M$GGT."(D.FSJ"3@Y] ,URNC:E8R_"Q[VXGU33;>XU>:1!I(S(NXDA?\ =KS
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
